All pacibekitug articles
-
News
Novartis expands in cardiovascular disease with $1.4bn Tourmaline Bio acquisition
Gains access to potential breakthrough atherosclerotic cardiovascular disease biologic therapy pacibekitug.
Gains access to potential breakthrough atherosclerotic cardiovascular disease biologic therapy pacibekitug.